Edward P. Feener - Jan 11, 2023 Form 4 Insider Report for KalVista Pharmaceuticals, Inc. (KALV)

Role
Chief Scientific Officer
Signature
/s/ Benjamin L. Palleiko, Attorney-in-Fact
Stock symbol
KALV
Transactions as of
Jan 11, 2023
Transactions value $
-$18,118
Form type
4
Date filed
5/19/2023, 09:18 PM
Previous filing
Nov 21, 2022
Next filing
May 22, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction KALV Common Stock Options Exercise +4.21K +6.53% 68.6K May 17, 2023 Direct F1
transaction KALV Common Stock Sale -$18.1K -1.79K -2.61% $10.14 66.8K May 18, 2023 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KALV Restricted Stock Unit Award $0 +29.2K $0.00 29.2K Jan 11, 2023 Common Stock 29.2K Direct F1, F3
transaction KALV Restricted Stock Unit Options Exercise $0 -2.43K -9.09% $0.00 24.3K May 17, 2023 Common Stock 2.43K Direct F1, F3
transaction KALV Restricted Stock Unit Options Exercise $0 -1.77K -7.69% $0.00 21.3K May 17, 2023 Common Stock 1.77K Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration.
F2 The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person.
F3 1/12th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on November 17, 2022, for a period of three years, subject to continued service through each vesting date.
F4 1/16th of the total number of shares subject to the RSU shall vest on each quarterly anniversary of the Vesting Commencement Date commencing on May 17, 2022, subject to continued service through each vesting date.